Kamada (KMDA) Cash from Financing Activities (2013 - 2026)

Kamada (KMDA) reported Cash from Financing Activities of -$856000.0 for Q1 2026, down 192.15% on a YoY basis from $928918.5 in Q1 2025, and up 27.4% quarter-over-quarter from -$1.2 million in Q4 2025.

Kamada (KMDA) Cash from Financing Activities (2013 - 2026) Analysis & Trends

Kamada has reported Cash from Financing Activities for 14 years, with the latest figure at -$856000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities fell 192.15% year-over-year to -$856000.0; the trailing twelve-month figure through Mar 2026 stood at -$18.9 million (down 123.37% YoY), and the FY2025 full-year result was -$18.3 million, down 31.87% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at -$856000.0, up from -$1.2 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $31.3 million in Q3 2023, with the low at -$16.1 million in Q2 2025.
  • Historically, Cash from Financing Activities has averaged -$961184.8 across 5 years, with a median of -$1.6 million in 2023.
  • Annual changes were most pronounced in 2023 — Cash from Financing Activities jumped 1384222.07% — and 2024, when it tumbled 199101.67%.
  • Kamada's Cash from Financing Activities stood at -$2.9 million in 2022, then surged by 44.93% to -$1.6 million in 2023, then surged by 55.22% to -$708000.0 in 2024, then sank by 66.53% to -$1.2 million in 2025, then climbed by 27.4% to -$856000.0 in 2026.
  • The last three Cash from Financing Activities figures came in at -$856000.0 (Q1 2026), -$1.2 million (Q4 2025), and -$754000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 13.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.47 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -77.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -11.62 Mn
10 Kamada 504.70 -73.15 Mn 19.12 Mn -856,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -856,000.00
Mar 31, 2026 -856,000.00
Dec 31, 2025 -1.18 Mn
Dec 31, 2025 -1.18 Mn
Sep 30, 2025 -754,000.00
Sep 30, 2025 -754,000.00
Jun 30, 2025 -16.12 Mn
Jun 30, 2025 -16.12 Mn
Mar 31, 2025 -293,000.00
Mar 31, 2025 -293,000.00
Dec 31, 2024 -708,000.00
Dec 31, 2024 -708,000.00
Sep 30, 2024 -4.79 Mn
Sep 30, 2024 -4.79 Mn
Jun 30, 2024 -2.68 Mn
Jun 30, 2024 -2.68 Mn
Mar 31, 2024 -5.74 Mn
Mar 31, 2024 -5.74 Mn
Dec 31, 2023 -1.58 Mn
Dec 31, 2023 -1.58 Mn